EBSAM
AMED
Eubel Brady & Suttman Asset Management’s Amedisys AMED Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $811K | Buy |
8,239
+1,358
| +20% | +$134K | 0.1% | 57 |
|
|
2025
Q1 | $637K | Sell |
6,881
-1,620
| -19% | -$150K | 0.08% | 61 |
|
|
2024
Q4 | $772K | Buy |
8,501
+62
| +0.7% | +$5.63K | 0.1% | 59 |
|
|
2024
Q3 | $814K | Hold |
8,439
| – | – | 0.11% | 58 |
|
|
2024
Q2 | $775K | Buy |
8,439
+3,368
| +66% | +$309K | 0.11% | 60 |
|
|
2024
Q1 | $467K | Buy |
5,071
+2,483
| +96% | +$229K | 0.06% | 68 |
|
|
2023
Q4 | $246K | Hold |
2,588
| – | – | 0.03% | 84 |
|
|
2023
Q3 | $242K | Hold |
2,588
| – | – | 0.04% | 86 |
|
|
2023
Q2 | $237K | Buy |
+2,588
| New | +$237K | 0.03% | 84 |
|
|
2021
Q3 | – | Sell |
-100
| Closed | -$26K | – | 82 |
|
|
2021
Q2 | $26K | Buy |
+100
| New | +$26K | ﹤0.01% | 423 |
|